Johnson & Johnson (JNJ) Offering Possible 21.07% Return Over the Next 21 Calendar Days

Johnson & Johnson’s most recent trend suggests a bullish bias. One trading opportunity on Johnson & Johnson is a Bull Put Spread using a strike $136.00 short put and a strike $131.00 long put offers a potential 21.07% return on risk over the next 21 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $136.00 by expiration. The full premium credit of $0.87 would be kept by the premium seller. The risk of $4.13 would be incurred if the stock dropped below the $131.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Johnson & Johnson is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Johnson & Johnson is bullish.

The RSI indicator is at 75.4 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for Johnson & Johnson

Sarantis Keeps Growing Year After Year
Wed, 27 Nov 2019 19:06:16 +0000
Greek based Sarantis manufactures consumer products for primarily for Greece and Eastern Europe. Continue reading…

Possible criminal probe undermines recovery in opioid stocks since global legal settlement announced
Wed, 27 Nov 2019 17:36:00 +0000
The stock prices of opioid drugmakers and distributors fell this week after news of a possible federal criminal probe, eroding many of the gains made in the weeks since a global settlement resolving opioid litigation was first announced.

Opioid Stocks Fall on News of Federal Criminal Investigation
Wed, 27 Nov 2019 14:37:00 +0000
Shares of companies caught up in the opioid litigation have risen recently, but a Wall Street Journal report appears to have reminded investors that the trouble could continue.

Health Care ETFs Are Breaking Out, But Political Risks Linger In 2020
Wed, 27 Nov 2019 14:35:07 +0000
The health care sector has shed its laggard ways as highlighted by the Health Care Select Sector SPDR (NYSE: XLV). While health care stocks have certainly snapped out of the slumbers they were in for much of this year, some of the same issues that hampered the group in 2019 aren’t likely to go away next. For XLV components like Johnson & Johnson (NYSE: JNJ), opioid litigation risk is palatable because those companies have the balance sheets to withstand the litigation and some if not most of that risk is baked into the stocks.

Should iShares Russell Top 200 Value ETF (IWX) Be on Your Investing Radar?
Wed, 27 Nov 2019 13:10:01 +0000
Style Box ETF report for IWX

Be Sociable, Share!

Related Posts